Programma finale completo - SIF - Università degli Studi di Torino
Programma finale completo - SIF - Università degli Studi di Torino
Programma finale completo - SIF - Università degli Studi di Torino
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
189. A comparison of exenatide and insulin glargine in patients using a single oral<br />
anti<strong>di</strong>abetic agent<br />
Gentilella Raffaella 5 ,Barnett A.H. 1 , Trautmann M. 2 , Burger J. 3 , Johns D. 3 , Kim D. 4 , Brodows<br />
R. 3 , Festa A. 2 , Roberts A. 2<br />
1 Department of Diabetes/Endocrinology, Birmingham Heartlands Hospital, United Kingdom,<br />
2 Eli Lilly and Company, Hamburg, Germany, 3 Eli Lilly and Company, In<strong>di</strong>anapolis, United<br />
States, 4 Amylin Pharmaceuticals, Inc., San Diego, United States; 5 Eli Lilly Italy, Florence, Italy<br />
190. Safety and efficacy of exenatide over 16 weeks in patients with type 2 <strong>di</strong>abetes<br />
mellitus using a thiazoli<strong>di</strong>ne<strong>di</strong>one with or without metformin<br />
Gentilella Raffaella 6 , Zinman B. 1 , Hoogwerf B. 2 , Duran Garcia S. 3 , Milton D. 4 , Giaconia J. 4 , Kim<br />
D. 5 , Trautmann M. 7 , Brodows R. 4<br />
1 Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada, 2 Department of<br />
Endocrinology, Cleveland Clinic Foundation, Cleveland, USA, 3 Cátedra de Endocrinología,<br />
Hospital de Valme, Sevilla, Spain, 4 Eli Lilly and Company, In<strong>di</strong>anapolis, USA, 5 Amylin<br />
Pharmaceuticals, Inc., San Diego, USA, 6 Eli Lilly Italy, Florence, Italy, 7 Eli Lilly and Company,<br />
Hamburg, Germany<br />
191. Beta-cell function is markedly reduced in women with previous gestational <strong>di</strong>abetes<br />
Canu Silvia 1 , Franconi F. 1 , Tesi F. 2 , Seghieri G. 2<br />
1 Dpt. of Pharmacology, University of Sassari, Italy. 2 Dpt. of Internal Me<strong>di</strong>cine, Spedali Riuniti,<br />
Pistoia<br />
100<br />
192. Concentration of brain natriuretic peptide in women with gestational <strong>di</strong>abetes<br />
2 Campesi Ilaria,<br />
1 Tesi F., 1 Gironi A. 2 Canu S., 2 De Bellis A., 1 Anichini R., 1 Seghieri G.,<br />
2 Franconi F.<br />
1 Dpt. of Internal Me<strong>di</strong>cine, Spedali Riuniti, Pistoia, 2 Dpt. of Pharmacology, University of<br />
Sassari, Italy<br />
193. Biochemical mechanisms underlying endocannabinoid dysregulation in the pancreas<br />
and a<strong>di</strong>pose tissue of high fat <strong>di</strong>et-fed mice<br />
Matias Isabelle 1 , Starowicz K. 1 , Cristino L. 2 , Racioppi A. 1 , Di Marzo V. 1<br />
1,2 Endocannabinoid Research Group, 1 Institute of Biomolecular Chemistry and 2 Institute of<br />
Cybernetics, Consiglio Nazionale delle Ricerche, Pozzuoli (NA), Italy<br />
194. Ghrelin and des-acyl ghrelin inhibit isoproterenol-induced lipolysis in rat a<strong>di</strong>pocytes<br />
through activation of phospho<strong>di</strong>esterase 3B<br />
Baragli Alessandra, Ghè C., Arnoletti E., Muccioli G.<br />
Division of Pharmacology, Department of Anatomy, Pharmacology and Forensic Me<strong>di</strong>cine,<br />
University of Turin, Turin, Italy<br />
195. Pharmacological modulation of metabolic, hormonal, and inflammatory alterations<br />
in an experimental model of hepatic steatosis<br />
1 Iacono Anna, 1,4 Esposito E., 1 Mattace Raso G., 2 Bianco G., 3,4 Cuzzocrea S., 1 Meli R.<br />
1 Department of Experimental Pharmacology, University of Naples “Federico II”, Naples;<br />
2 Department of Pharmaceutical Sciences, University of Salerno; 3 Department of Clinical and<br />
Experimental Me<strong>di</strong>cine and Pharmacology, School of Me<strong>di</strong>cine, University of Messina, Messina;<br />
4 IRCCS Centro Neurolesi "Bonino-Pulejo," Messina, Italy<br />
pag_sx.indd 1 30/05/2007 4.34.12